These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

874 related articles for article (PubMed ID: 30227870)

  • 1. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
    He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
    J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-646 suppresses proliferation and metastasis of non-small cell lung cancer by repressing FGF2 and CCND2.
    Wang J; Shu H; Guo S
    Cancer Med; 2020 Jun; 9(12):4360-4370. PubMed ID: 32347652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-504 inhibits cell proliferation and invasion by targeting LOXL2 in non small cell lung cancer.
    Ye MF; Zhang JG; Guo TX; Pan XJ
    Biomed Pharmacother; 2018 Jan; 97():1289-1295. PubMed ID: 29156517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
    Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
    J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
    Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
    Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR‑671‑3p is downregulated in non‑small cell lung cancer and inhibits cancer progression by directly targeting CCND2.
    Yao Y; Zhou Y; Fu X
    Mol Med Rep; 2019 Mar; 19(3):2407-2412. PubMed ID: 30664171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2.
    Li YL; Wang J; Zhang CY; Shen YQ; Wang HM; Ding L; Gu YC; Lou JT; Zhao XT; Ma ZL; Jin YX
    Oncotarget; 2016 Sep; 7(37):59287-59298. PubMed ID: 27494902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-598 Suppresses Invasion and Migration by Negative Regulation of Derlin-1 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
    Yang F; Wei K; Qin Z; Liu W; Shao C; Wang C; Ma L; Xie M; Shu Y; Shen H
    Cell Physiol Biochem; 2018; 47(1):245-256. PubMed ID: 29768262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circular RNA circ-RAD23B promotes cell growth and invasion by miR-593-3p/CCND2 and miR-653-5p/TIAM1 pathways in non-small cell lung cancer.
    Han W; Wang L; Zhang L; Wang Y; Li Y
    Biochem Biophys Res Commun; 2019 Mar; 510(3):462-466. PubMed ID: 30722989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-138 suppresses the proliferation, metastasis and autophagy of non-small cell lung cancer by targeting Sirt1.
    Ye Z; Fang B; Pan J; Zhang N; Huang J; Xie C; Lou T; Cao Z
    Oncol Rep; 2017 Jun; 37(6):3244-3252. PubMed ID: 28498463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25.
    Li J; Tan Q; Yan M; Liu L; Lin H; Zhao F; Bao G; Kong H; Ge C; Zhang F; Yu T; Li J; He X; Yao M
    Mol Cancer; 2014 Jul; 13():166. PubMed ID: 24997798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-126-3p suppresses the growth, migration and invasion of NSCLC via targeting CCR1.
    Liu R; Zhang YS; Zhang S; Cheng ZM; Yu JL; Zhou S; Song J
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):679-689. PubMed ID: 30720175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-187 suppresses non-small-cell lung cancer cell proliferation by targeting FGF9.
    Liang Z; Xu J; Ma Z; Li G; Zhu W
    Bioengineered; 2020 Dec; 11(1):70-80. PubMed ID: 31884893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-582-5p is a potential prognostic marker in human non-small cell lung cancer and functions as a tumor suppressor by targeting MAP3K2.
    Wang LL; Zhang M
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7760-7767. PubMed ID: 30536321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-615 Inhibits Prostate Cancer Cell Proliferation and Invasion by Directly Targeting Cyclin D2.
    Huang F; Zhao H; Du Z; Jiang H
    Oncol Res; 2019 Feb; 27(3):293-299. PubMed ID: 29471894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1.
    Shi Q; Zhou Z; Ye N; Chen Q; Zheng X; Fang M
    Cancer Biomark; 2017 Dec; 20(4):539-546. PubMed ID: 28946554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of miR-4286 is an unfavorable prognostic marker in individuals with non-small cell lung cancer.
    An X; Ge J; Guo H; Mi H; Zhou J; Liu Y; Weiyue ; Wu Z
    J Cell Biochem; 2019 Oct; 120(10):17573-17583. PubMed ID: 31111550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.